# ImmunoGen Inc. (IMGN)

Source: https://www.quantisnow.com/company/IMGN
Generated: 2026-10-30T21:00:11.075Z

- Ticker: IMGN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 1989
- Website: immunogen.com

## About

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S. LLC; Biotest AG; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Fusion Pharmaceuticals Inc.; Debiopharm International SA; Jazz Pharmaceuticals Ireland Limited; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

## Latest IMGN news and filings

- 2025-01-22 16:05 UTC [Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research](https://www.quantisnow.com/insight/antibody-drug-conjugates-market-size-is-expected-to-reach-usd-5853230)
- 2024-11-05 12:05 UTC [Leadership Update] [PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer](https://www.quantisnow.com/insight/puretech-founded-entity-seaport-therapeutics-names-lauren-white-as-chief-5752264)
- 2024-11-05 12:00 UTC [Leadership Update] [Seaport Therapeutics Names Lauren White as Chief Financial Officer](https://www.quantisnow.com/insight/seaport-therapeutics-names-lauren-white-as-chief-financial-officer-5752204)
- 2024-03-26 19:38 UTC [March 26, 2024
 - FDA Roundup: March 26, 2024](https://www.quantisnow.com/insight/march-26-2024---fda-roundup-march-26-2024-5369201)
- 2024-03-22 17:48 UTC [FDA Approval for ELAHERE issued to IMMUNOGEN INC](https://www.quantisnow.com/insight/fda-approval-for-elahere-issued-to-immunogen-inc-5363465)
- 2024-02-22 21:15 UTC [SEC Form 15-12G filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-immunogen-inc-5284803)
- 2024-02-14 22:01 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-immunogen-inc-amendment-5264792)
- 2024-02-14 21:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-immunogen-inc-amendment-5263842)
- 2024-02-13 22:06 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-immunogen-inc-amendment-5256666)
- 2024-02-12 21:48 UTC [SEC Form 4] [Mitchell Dean J returned 103,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/mitchell-dean-j-returned-103000-shares-to-the-company-closing-5250929)
- 2024-02-12 21:48 UTC [SEC Form 4] [SEC Form 4 filed by Peterson Kristine](https://www.quantisnow.com/insight/sec-form-4-filed-by-peterson-kristine-5250917)
- 2024-02-12 21:47 UTC [SEC Form 4] [Thackray Helen M. returned 3,074 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/thackray-helen-m-returned-3074-shares-to-the-company-closing-5250909)
- 2024-02-12 21:46 UTC [SEC Form 4] [Enyedy Mark J returned 584,397 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/enyedy-mark-j-returned-584397-shares-to-the-company-closing-5250898)
- 2024-02-12 21:45 UTC [SEC Form 4] [Wallace Richard John returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/wallace-richard-john-returned-10000-shares-to-the-company-closing-5250885)
- 2024-02-12 21:44 UTC [SEC Form 4] [Coen Stacy Ann returned 73,274 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/coen-stacy-ann-returned-73274-shares-to-the-company-closing-5250875)
- 2024-02-12 21:43 UTC [SEC Form 4] [Lentini Renee returned 14,723 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/lentini-renee-returned-14723-shares-to-the-company-closing-all-5250860)
- 2024-02-12 21:42 UTC [SEC Form 4] [Goldberg Mark Alan returned 60,720 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/goldberg-mark-alan-returned-60720-shares-to-the-company-closing-5250849)
- 2024-02-12 21:41 UTC [SEC Form 4] [Arbuckle Stuart A returned 5,381 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/arbuckle-stuart-a-returned-5381-shares-to-the-company-closing-5250834)
- 2024-02-12 21:41 UTC [SEC Form 4] [Wingrove Theresa returned 21,039 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/wingrove-theresa-returned-21039-shares-to-the-company-closing-all-5250828)
- 2024-02-12 21:40 UTC [SEC Form 4] [SEC Form 4 filed by Mccluski Stephen C](https://www.quantisnow.com/insight/sec-form-4-filed-by-mccluski-stephen-c-5250817)
- 2024-02-12 21:39 UTC [SEC Form 4] [SEC Form 4 filed by Mccain Tracey L](https://www.quantisnow.com/insight/sec-form-4-filed-by-mccain-tracey-l-5250802)
- 2024-02-12 21:38 UTC [SEC Form 4] [SEC Form 4 filed by Kalofonos Isabel](https://www.quantisnow.com/insight/sec-form-4-filed-by-kalofonos-isabel-5250795)
- 2024-02-12 21:37 UTC [SEC Form 4] [SEC Form 4 filed by White Lauren](https://www.quantisnow.com/insight/sec-form-4-filed-by-white-lauren-5250788)
- 2024-02-12 21:36 UTC [SEC Form 4] [Char Daniel returned 1,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/char-daniel-returned-1000-shares-to-the-company-closing-all-5250776)
- 2024-02-12 21:35 UTC [SEC Form 4] [Vasconcelles Michael returned 1,327 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/vasconcelles-michael-returned-1327-shares-to-the-company-closing-all-5250759)
- 2024-02-12 21:33 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250709)
- 2024-02-12 21:32 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250696)
- 2024-02-12 21:27 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250589)
- 2024-02-12 21:26 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250582)
- 2024-02-12 21:26 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250571)
- 2024-02-12 21:25 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250563)
- 2024-02-12 21:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250548)
- 2024-02-12 21:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250536)
- 2024-02-12 21:23 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250519)
- 2024-02-12 21:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250497)
- 2024-02-12 21:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250486)
- 2024-02-12 21:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250478)
- 2024-02-12 21:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250474)
- 2024-02-12 21:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250469)
- 2024-02-12 21:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ImmunoGen Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-immunogen-inc-5250457)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IMGN
- RSS and alerts for IMGN: https://www.quantisnow.com/docs/rss-feeds.md